You just read:

EpiThany Announces Clinical Collaboration with Merck KGaA, Darmstadt, Germany, and Pfizer to Evaluate Combination of Avelumab and EP-101 STEMVAC in Breast Cancer

News provided by

EpiThany

May 10, 2017, 08:00 ET